October 19-26, 2019
39 participants, 27 women, 12 men from 10 countries
Faculty
J. Ambler, Wockhardt Pharmaceuticals, USA; D. Andes, University of Wisconsin, USA; C. Arias, University of Texas, USA; M. Arthur, Sorbonne Université, France; D. Bikard, Institut Pasteur, France; S. Brisse, Institut Pasteur, France; E. Brown, McMaster University, Canada; G. Challis, University of Warwick, UK; J.‑P. Charrier, bioMérieux, France; J.‑F. Collet, Université de Louvain, Belgique; P. Courvalin, Institut Pasteur, France; L. De Sordi, Sorbonne Université, France; J.‑D. Docquier, University of Siena, Italy; M. Doubovetzky, Sanofi, France; T. Dougherty, Harvard Medical School, USA; E. Duffy, CARB-X, USA; F. Fang, University of Washington, USA; M. Fisher, St Georges University, UK; M. Gilmore, Harvard Medical School, USA; J. Guglielmini, Institut Pasteur, France; L. Hall-Stoodley, Ohio State University, USA; S. Harbarth, Hopitaux de Genève, Switzerland; D. Hughes, Uppsala University, Sweden; S. Lahiri, Boehringer Ingelheim, USA; F. Lebreton, Harvard Medical School, USA; M. Lipsitch, Harvard Medical School, USA; S. Lory, Harvard Medical School, USA; B. Luisi, University of Cambridge, UK; A. Mankin, University of Illinois, USA; H. Moser, Novartis, USA; A. Myers, Harvard University, USA; M. Page, Basel, Switzerland; E. Pamer, University of Chicago, USA; S. Projan, Arsanis Inc, USA; M. Pucci, Spero Therapeutics, USA; J. Rex, F2G, UK; H.‑G. Sahl, University of Bonn, Germany; M.‑W. Tan, Genentech/Roche, USA; U. Theuretzbacher, CAIA, Austria; M. Vazquez-Laslop, University of Illinois, USA; G. Wright, McMaster University, Canada
